Who would have supposed that after several prior serious viral outbreaks, including SARS, MERS and the swine flu, the United States would find itself so short of the diagnostic tests needed to combat the COVID-19 pandemic? Yet,… Read More »
The coronavirus has sufficiently disrupted life that it has our closest attention. And the private sector’s response — initiative, innovation and intrepidity — is inspirational. Private-sector medical research-and-development innovators, such as biopharmaceutical companies and clinical labs, are… Read More »
At government, university, and private-sector research labs across the country, scientists are working around the clock to better understand the coronavirus. The resulting lab breakthroughs could soon become experimental treatments and vaccines. According to the Milken Institute… Read More »
With two-thirds of the world in lockdown and no clear way out of the novel coronavirus crisis, it’s increasingly obvious that biopharmaceutical innovation will play a pivotal role. A new treatment that can mitigate the worst effects… Read More »
By the time Texas Instruments’ Jack Kilby and Fairchild Semiconductor’s Robert Noyce invented the integrated chip in the late 1950s, the U.S. patent system had become firmly established. Alas, the world’s patent “gold standard” has lately suffered… Read More »
“The COVID-19 crisis has once more highlighted the need for incentivizing investment and innovation—and thus, for patent laws that duly “promote” and protect such “progress,” precisely as our Founders envisioned,” writes Chief Judge Paul Michel, now retired from the… Read More »
China in 2019 surpassed the United States of America (U.S.) as the top source of international patent applications filed with WIPO amid another year of robust growth for the Organization’s international intellectual property (IP) services, treaty-adherence activity and revenue… Read More »
As the father of three girls, I sometimes get a little overwhelmed when thinking about COVID-19 and social distancing. They, as many are, are losing out on school, birthday parties, playing with friends, and just the basic… Read More »
As the urgency of finding a treatment and vaccine for the coronavirus accelerates, dozens of American biomedical companies, startups and universities are rushing to develop COVID-19 therapeutics. There’s a good chance the Bayh-Dole Act will play a… Read More »
The world is teetering on the brink of a public health and economic catastrophe, depending on emergency partnerships between our public and private sectors to develop a successful treatment for the coronavirus. If there was ever a… Read More »
